Linicor
0472.282.607 · rovalta.com · 21/09/2026
ACTIVE
Linicor
Financial year 2025 · closed on 31/12/2025
Net result
119,4 k €
+58.8% YoY
Gross margin
213,1 k €
+41.4% YoY
Equity
407,1 k €
+41.5% YoY
Overview
What does Linicor do?
Linicor is a Public limited company incorporated in 2000. Its main activity is: Translation and interpretation activities. Its registered office is in Damme.
Legal situation
● Normal situation
BCE/KBO no. / VAT
BE 0472.282.607
Incorporation
04/07/2000
Legal form
Public limited company
Registered office
Dorpsstraat 106
8340 Damme · FlandreSee on map
8340 Damme · FlandreSee on map
Contributed capital
62 000,00 €
Latest accounts
31/12/2025
Activities (NACE)
Joint committees (3)
- 207
- 305
- 330
Signals
ProfitableLow riskGood liquidityPositive cashflowPositive EBITDA
Available with a Rovalta subscriptionTry for 7 days
Financials
Trend over 18 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||||||||||||||||||||||||||||
| Gross margin | 213,1 k € | +41.4% | 150,7 k € | -13.5% | 174,2 k € | +302% | 43,3 k € | +238% | 12,8 k € | +652% | 1,7 k € | -94.5% | 31,0 k € | -9.6% | 34,3 k € | -28.6% | 48,0 k € | -3.5% | 49,8 k € | +11.0% | 44,9 k € | -2.8% | 46,2 k € | -73.4% | 173,5 k € | -36.6% | 273,5 k € | -2.6% | 280,7 k € | +1.5% | 276,7 k € | +11.5% | 248,2 k € | -7.5% | 268,4 k € |
| EBITDA | 211,6 k € | +41.7% | 149,3 k € | -13.9% | 173,3 k € | +309% | 42,4 k € | +276% | 11,3 k € | +1907% | 562,2 € | -98.2% | 30,4 k € | -10.2% | 33,9 k € | -28.9% | 47,6 k € | -3.6% | 49,4 k € | +11.1% | 44,4 k € | -2.8% | 45,7 k € | -4.2% | 47,7 k € | +16.3% | 41,1 k € | +21.9% | 33,7 k € | +61.3% | 20,9 k € | -35.0% | 32,1 k € | -41.4% | 54,9 k € |
| Operating result | 213,5 k € | +41.0% | 151,4 k € | -13.7% | 175,5 k € | +314% | 42,4 k € | +751% | 5,0 k € | +187% | -5,7 k € | -123% | 24,5 k € | -27.6% | 33,9 k € | -28.4% | 47,3 k € | -3.6% | 49,0 k € | +11.2% | 44,1 k € | -3.5% | 45,7 k € | -4.2% | 47,7 k € | +26.5% | 37,7 k € | +24.2% | 30,4 k € | +91.7% | 15,9 k € | -47.8% | 30,4 k € | -40.7% | 51,3 k € |
| Net result | 119,4 k € | +58.8% | 75,2 k € | -16.6% | 90,1 k € | +5408% | 1,6 k € | -40.1% | 2,7 k € | +145% | -6,1 k € | -148% | 12,5 k € | -43.2% | 22,0 k € | -30.0% | 31,4 k € | -12.9% | 36,1 k € | +17.7% | 30,7 k € | -1.0% | 31,0 k € | +1.5% | 30,5 k € | +30.0% | 23,5 k € | +35.1% | 17,4 k € | +205% | 5,7 k € | -70.9% | 19,6 k € | -36.8% | 31,0 k € |
| Balance sheet | |||||||||||||||||||||||||||||||||||
| Equity | 407,1 k € | +41.5% | 287,7 k € | +3.5% | 277,8 k € | +48.0% | 187,7 k € | +0.9% | 186,1 k € | +4.1% | 178,7 k € | -3.3% | 184,8 k € | +7.3% | 172,3 k € | +14.6% | 150,3 k € | +26.5% | 118,8 k € | +43.6% | 82,8 k € | -39.6% | 137,1 k € | +29.2% | 106,1 k € | +40.4% | 75,6 k € | +9.4% | 69,1 k € | +0.6% | 68,7 k € | -21.9% | 88,0 k € | -5.8% | 93,4 k € |
| Total assets | 1,5 M € | +2.7% | 1,5 M € | -0.2% | 1,5 M € | +3.8% | 1,4 M € | +93.8% | 740,0 k € | +0.6% | 735,3 k € | -0.8% | 741,0 k € | +288% | 191,0 k € | +19.2% | 160,2 k € | +21.2% | 132,2 k € | -37.0% | 209,9 k € | +30.3% | 161,1 k € | +28.7% | 125,2 k € | -30.3% | 179,6 k € | +13.5% | 158,3 k € | -26.9% | 216,4 k € | +13.7% | 190,4 k € | -14.5% | 222,6 k € |
| Cash | 70,7 k € | -27.3% | 97,3 k € | +27.6% | 76,3 k € | +104% | 37,4 k € | -78.3% | 172,8 k € | +30.7% | 132,2 k € | -11.1% | 148,7 k € | -11.0% | 167,1 k € | +26.4% | 132,2 k € | +24.1% | 106,5 k € | -34.5% | 162,6 k € | +32.5% | 122,8 k € | +189% | 42,5 k € | +238% | 12,5 k € | -21.2% | 15,9 k € | -42.3% | 27,6 k € | +90.9% | 14,5 k € | +1.8% | 14,2 k € |
| Debts | 620,3 k € | -10.7% | 694,5 k € | -1.9% | 708,3 k € | -5.0% | 745,7 k € | +34.6% | 553,9 k € | -0.5% | 556,6 k € | +0.1% | 556,2 k € | +2876% | 18,7 k € | +88.0% | 9,9 k € | -25.3% | 13,3 k € | -89.5% | 127,2 k € | +430% | 24,0 k € | +25.8% | 19,1 k € | -81.6% | 104,0 k € | +16.6% | 89,2 k € | -39.6% | 147,7 k € | +44.3% | 102,4 k € | -7.9% | 111,2 k € |
| Other | |||||||||||||||||||||||||||||||||||
| Workforce | – | – | – | – | – | – | – | – | – | – | – | – | 1,6 ETP | -61.9% | 4,2 ETP | 0.0% | 4,2 ETP | 0.0% | 4,2 ETP | 0.0% | 4,2 ETP | +2.4% | 4,1 ETP | ||||||||||||
Estimate
Indicative valuation
As an indication, this company is worth
between 500 k€ and 1 M€
See the valuationGovernance
Board of directors
Seen on filing of 31/12/2025 · 2 active · 15 ended
Active mandates
Active
Pauline Cordonnier
ActiveEnded mandates
At this address
Other companies at this address
| Company | CBE no. |
|---|---|
APOCHEM● Active | 0479.416.560 |
Apotheek Leenesonne● Active | 0447.847.416 |
BIOCONTROL● Active | 0433.949.888 |
Financials
Annual accounts
Full financial information
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 31/08/2026 | 12/07/2025 | 29/07/2024 | 14/07/2023 | 31/07/2022 | 20/08/2021 |
| General meeting | 31/07/2026 | 11/06/2025 | 12/06/2024 | 14/06/2023 | 08/06/2022 | 09/06/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Ratios
Financial ratios
Looking for more information about this company?
Try for 7 daysFilings
Annual accounts filings
19 filings with the NBB
| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Abridged model | 31/12/2025 | 31/07/2026 | 31/08/2026 | Dutch | |
| Abridged model | 31/12/2024 | 11/06/2025 | 12/07/2025 | Dutch | |
| Abridged model | 31/12/2023 | 12/06/2024 | 29/07/2024 | Dutch | |
| Abridged model | 31/12/2022 | 14/06/2023 | 14/07/2023 | Dutch | |
| Abridged model | 31/12/2021 | 08/06/2022 | 31/07/2022 | Dutch | |
| Abridged model | 31/12/2020 | 09/06/2021 | 20/08/2021 | Dutch | |
| Abridged model | 31/12/2019 | 10/06/2020 | 25/06/2020 | Dutch | |
| Abridged model | 31/12/2018 | 12/06/2019 | 29/07/2019 | Dutch | |
| Abridged model | 31/12/2017 | 13/06/2018 | 01/08/2018 | Dutch | |
| Abridged model | 31/12/2016 | 14/06/2017 | 28/06/2017 | Dutch | |
| Abridged model | 31/12/2015 | 08/06/2016 | 31/08/2016 | Dutch | |
| Abridged model | 31/12/2014 | 10/06/2015 | 31/08/2015 | Dutch | |
| Abridged model | 31/12/2013 | 11/06/2014 | 30/09/2014 | Dutch | |
| Abridged model | 31/12/2012 | 12/06/2013 | 30/08/2013 | Dutch | |
| Abridged model | 31/03/2011 | 21/09/2011 | 04/11/2011 | Dutch | |
| Abridged model | 31/03/2010 | 15/09/2010 | 29/10/2010 | Dutch | |
| Abridged model | 31/03/2009 | 16/09/2009 | 26/10/2009 | Dutch | |
| Abridged model | 31/03/2008 | 17/09/2008 | 24/11/2008 | Dutch | |
| Abridged model | 31/03/2007 | 19/09/2007 | 19/10/2007 | Dutch |
Valuation
Estimate
Indicative valuation
Order of magnitude
As an indication, this company is worth
between 500 k€ and 1 M€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Disclaimer
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Governance
Board of directors
Seen on filing of 31/12/2025 · 2 active · 15 ended
Active mandates
Active
Pauline Cordonnier
ActiveEnded mandates
Shareholders
Ownership and network
Looking for more information about this company?
Try for 7 daysPublications
Belgian Official Gazette
Belgian Official Gazette publications
- Mandates12/12/2023STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - ONTSLAGEN - BENOEMINGEN
- Mandates28/07/2022ONTSLAGEN - BENOEMINGEN
- Mandates11/09/2018ONTSLAGEN - BENOEMINGEN
- Other13/03/2014DOEL
- Other16/10/2013BENAMING - STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, )
- Mandates02/10/2012MAATSCHAPPELIJKE ZETEL - ONTSLAGEN - BENOEMINGEN
- Other19/04/2012STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, )
- Capital / shares16/01/2012STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - KAPITAAL - AANDELEN
Source: Belgian Official Gazette
Similar companies
Competition
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2025Annual accounts 2025119,4 k €↑
- 2024Annual accounts 202475,2 k €↓
- 2023Annual accounts 202390,1 k €↑
- 2022Annual accounts 20221,6 k €↓
- 2021Annual accounts 20212,7 k €↑
- 2019Annual accounts 2019-6,1 k €↓
- 2018Annual accounts 201812,5 k €↓
- 2017Annual accounts 201722,0 k €↓
- 2016Annual accounts 201631,4 k €↓
- 2015Annual accounts 201536,1 k €↑
- 2014Annual accounts 201430,7 k €↓
- 2013Annual accounts 201331,0 k €↑
- 2013Name changeLINICOR
- 2012Annual accounts 201230,5 k €↑
- 2011Annual accounts 201123,5 k €↑
- 2010Annual accounts 201017,4 k €↑
- 2009Annual accounts 20095,7 k €↓
- 2008Annual accounts 200819,6 k €↓
- 2007Annual accounts 200731,0 k €
- 2007Name changeCHEMIPHAR LEUVEN
- 04/07/2000IncorporationPublic limited company